Spotlight on Audicus and Jogo Health's Equity Crowdfunding Campaigns

In partnership with

Audicus Now Live on Wefunder

Transforming Hearing Health with Audicus

In the world of telehealth, Audicus is revolutionizing the hearing aid industry by providing high-quality, affordable solutions for those in need. The company’s mission to make hearing aids accessible and affordable for all has earned them a prominent place in the burgeoning telehealth sector. Here’s what investors need to know about this trailblazing company:

Investment Details:

• Funding Status: Audicus has raised nearly $140,000 from 76 investors in its current equity crowdfunding campaign, securing a pre-money valuation of $65 million.

• Revenue Run Rate: The company has a revenue run rate of $14 million, with over $10 million in annual recurring revenue.

• Subscription Model: Audicus’s business model includes a subscription revenue stream, growing at 65% year-over-year, with a robust LTV/CAC ratio exceeding 4x.

A New Era of Hearing Care:

Audicus is pioneering an innovative telehealth solution for hearing aids, offering remote hearing tests, customized aid delivery, and ongoing telecare support—all at a significantly reduced price compared to traditional methods. Their unique approach includes:

• Remote Hearing Tests: Users can complete a 15-minute hearing test using any headset, free of charge.

• Customized Aids: Based on test results, customized hearing aids are delivered directly to users’ doors.

• Ongoing Support: Through their app, Audicus provides telecare support, including remote adjustments and consultations.

Market Opportunity:

The hearing aid market represents an $8 billion opportunity, with over 40 million Americans experiencing hearing loss. Traditional brick-and-mortar clinics have dominated this space, often making aids inaccessible due to prohibitive costs and lengthy processes. Audicus is changing the game by offering a streamlined, affordable solution, addressing a massive underpenetrated market.

Impact and Recognition:

Audicus’s efforts have already saved users over $100 million in hearing aid costs, garnering a 4.7-star rating from over 9,000 reviews. Their team includes experienced professionals from MIT, Stanford, McKinsey, and industry giants like Bose, bringing deep industry knowledge to the company’s growth.

Final Thoughts:

Audicus is transforming the hearing aid industry with its tech-enabled telehealth solution, making quality hearing care accessible to all. The company’s streamlined, affordable approach positions it for significant growth, while its positive social impact has already made a profound difference. Investors looking for innovative companies with a solid mission and substantial market potential should keep a close eye on Audicus.

GaitBetter, a groundbreaking and innovative entity in the healthcare sector, is radically transforming the rehabilitation landscape with the help of its state-of-the-art virtual reality technology. By meticulously designing and creating immersive, controlled environments for patients, the company has helped patients overcome a multitude of mobility issues significantly. This innovative approach sets a fresh and unprecedented standard in patient care, marking a significant milestone in the evolution of rehabilitative therapy.

Read More

Crowdfunding Spotlight: Jogo Health

A Breakthrough in Treating Chronic Pain and Neuromuscular Disorders

Jogo Health is making waves in the healthcare industry by offering a revolutionary solution for treating chronic pain and neuromuscular disorders. The company’s unique approach, backed by wearable technology and telehealth services, aims to fill a crucial gap in healthcare options for millions of people worldwide. Here's what investors should know about this groundbreaking company:

Investment Overview:

• Funding Status: Jogo Health has raised over $5.4 million in its current equity crowdfunding campaign, reaching more than 70% of its $7.71 million goal. The company has a pre-money valuation of $37 million.

• Revenue Streams: Jogo’s services have treated over 25,000 patients across 50 hospital partners, resulting in revenue from over 100,000 patient sessions reimbursed by Medicare and commercial insurance.

A New Approach to Healthcare:

Jogo Health offers a non-invasive solution to chronic pain and neuromuscular disorders, leveraging the brain's natural neuroplasticity. Their wearable device and app provide relief for various conditions, including:

• Chronic Lower Back Pain: Jogo's solution has demonstrated greater effectiveness than opioids in treating chronic lower back pain, according to a Harvard Medical School study.

• Neuromuscular Conditions: The device and app offer clinically proven treatments for conditions like migraines, stroke recovery, and urinary incontinence.

Milestones and Market Opportunity:

• Key Achievements: Jogo Health has secured patents, FDA market authorization, and insurance reimbursement, allowing it to operate effectively within the healthcare industry.

• Market Impact: The company's solution targets the $380 billion global market for chronic pain and neuromuscular disorders, which affects over 1.5 billion people worldwide.

The Team Behind Jogo Health:

• Dr. Gordon Silverman: An EMG-BF pioneer, Dr. Silverman has led Jogo’s product vision and holds 8 patents.

• Siva Nadarajah: As co-founder and president, Siva has a track record of success in healthcare innovation, including a previous company acquisition by IQVIA for $47 billion.

• Sanjai Murali: Founder and CEO, Sanjai has guided Jogo from inception to its current success, leading the company to FDA market authorization and Medicare reimbursement.

Future Potential:

Jogo Health's innovative solution offers a safe, effective alternative to pharmaceuticals and surgery, positioning the company to further disrupt the healthcare industry. Backed by prominent investors like Mayo Clinic Ventures, Jogo Health's approach shows strong potential for continued growth and innovation.

Conclusion:

Jogo Health is transforming healthcare by providing a non-invasive, accessible solution for chronic pain and neuromuscular disorders. The company's growth and milestones signal a promising future for both patients and investors, making it a compelling opportunity for equity crowdfunding.

Invest in the Future of Scalable Housing

ZenniHome is on a mission to completely disrupt the housing industry.

Dr. Michael Schmitt has joined as COO (previously Tesla and Bosch).
$74M in grants awarded from Navajo Nation for factory expansion and home purchases

Closing soon: Learn more and Invest in ZenniHome